Showing 1771-1780 of 2314 results for "".
- CMS Proposes Changes to Docs’ Medicare Payments for 2021, Including Payment Cuts for Some Specialtieshttps://modernod.com/news/cms-proposes-changes-to-docs-medicare-payments-for-2021-including-payment-cuts-for-some-specialties/2478125/Federal health officials released a proposed rule that sets 2021 Medicare payment rates for physicians and includes changes to the Merit-based Incentive Payment System, according to a FierceHealthcare
- Face-to-Face Meetings Between Pharma and Doctors Are On the Uphttps://modernod.com/news/face-to-face-meetings-between-pharma-and-doctors-are-on-the-up/2478102/Second-quarter results reported to date by large-cap pharmaceutical and biotech companies illustrate that social distancing measures weighed heavily on topline drug revenues in April and May. In addition to slowing patient access to medicines, the COVID-19 pandemic has also forced the industry to
- Santen and NTC Release Results of Phase 3 Clinical Study Examining 7-Day Fixed Dose Combination of Levofloxacinhttps://modernod.com/news/santen-and-ntc-release-results-of-phase-3-clinical-study-examining-7-day-fixed-dose-combination-of-levofloxacin/2478007/Santen EMEA and NTC have announced that the results of their phase 3 clinical study, LEADER7, have been published in Eye. The study demonstrated for the first time that 7-day levofloxacin/dexamethasone eye dr
- The FDA Does Not Approve Allergan’s Wet AMD Drug Candidate Abicipar Pegolhttps://modernod.com/news/allergan-and-molecular-partners-receive-complete-response-letter-from-fda-on-biologics-license-application-for-abicipar-pegol/2477937/Citing an unfavorable benefit-risk ratio, the FDA rejected Allergan and co-developer Molecular Partners’ wet AMD drug candidate Abicipar pegol. The FDA issued a complete response letter to the biologics license application (BLA) for Abicipar pegol, a novel, investigational DARPin the
- AstraZeneca Targeting Over 2 Billion COVID-19 Vaccine Doses After Latest Dealshttps://modernod.com/news/astrazeneca-targeting-over-2-billion-covid-19-vaccine-doses-after-latest-deals/2477865/AstraZeneca said it signed agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance and the Serum Institute of India (SII) in a move aimed at broadening global access to an experimental COVID-19 vaccine being developed at the University of Oxford. The
- Yoga With Dr. Richardsonhttps://modernod.com/news/yoga-with-dr-richardson/2477693/
- As COVID-19 Shutters Practices Virtual Doc-Patient Activity Soarshttps://modernod.com/news/as-covid-19-shutters-practices-virtual-doc-patient-activity-soars/2477685/A new report shows the enormous increase in online messages and virtual interactions physicians have been having with their patients―out of necessity―since the beginning of the COVID-19 pandemic, according to a Medscape report. The
- Locked Down in Love … For Nowhttps://modernod.com/news/locked-down-in-love-for-now/2477667/
- Seniors With COVID-19 Show Unusual Symptoms, Doctors Sayhttps://modernod.com/news/seniors-with-covid-19-show-unusual-symptoms-doctors-say/2477655/Older adults with COVID-19 have several “atypical” symptoms, complicating efforts to ensure they get timely and appropriate treatment, according to physicians, as reported by Kaiser Health News. CO
- How Does Coronavirus Kill? Clinicians Trace a Ferocious Rampage Through the Bodyhttps://modernod.com/news/how-does-coronavirus-kill-clinicians-trace-a-ferocious-rampage-through-the-body/2477615/As the number of confirmed cases of COVID-19 surges past 2.2 million globally and deaths surpass 150,000, clinicians and pathologists are struggling to understand the damage wrought by the coronavirus as it tears through the body. They are realizing that although the lungs are ground zero, its re